Glaukos Long Term Debt 2014-2022 | GKOS
Glaukos long term debt from 2014 to 2022. Long term debt can be defined as the sum of all long term debt fields.
Glaukos Annual Long Term Debt
(Millions of US $) |
| 2022 |
$354 |
| 2021 |
$353 |
| 2020 |
$250 |
| 2019 |
$58 |
| 2018 |
$ |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$1 |
| 2014 |
$9 |
| 2013 |
$18 |
Glaukos Quarterly Long Term Debt
(Millions of US $) |
| 2022-12-31 |
$354 |
| 2022-09-30 |
$353 |
| 2022-06-30 |
$353 |
| 2022-03-31 |
$353 |
| 2021-12-31 |
$353 |
| 2021-09-30 |
$352 |
| 2021-06-30 |
$73 |
| 2021-03-31 |
$61 |
| 2020-12-31 |
$250 |
| 2020-09-30 |
$247 |
| 2020-06-30 |
$244 |
| 2020-03-31 |
$59 |
| 2019-12-31 |
$58 |
| 2019-09-30 |
$69 |
| 2019-06-30 |
$68 |
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
|
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-03-31 |
|
| 2016-12-31 |
|
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
|
| 2015-12-31 |
$1 |
| 2015-09-30 |
$3 |
| 2015-06-30 |
$12 |
| 2015-03-31 |
$14 |
| 2014-12-31 |
$9 |
| 2014-09-30 |
|
| 2014-06-30 |
|
| 2014-03-31 |
|
| 2013-12-31 |
$18 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$2.324B |
$0.283B |
|
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
|
